Flax lignan concentrate attenuate hypertension and abnormal left ventricular contractility via modulation of endogenous biomarkers in two-kidney-one-clip (2K1C) hypertensive rats  by Sawant, Sameer Hanmantrao & Bodhankar, Subhash Laxmanrao
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The  present  investigation  was  designed  to study  the  effect  of  ﬂax  lignan  concentrate  obtained  from  Linum
usitatissimum  L., Linaceae,  in  two-kidney,  one  clip  (2K1C)  hypertension  model  in Wistar  rats.  2K1C  Gold-
blatt model  rats  were  divided  randomly  into  six  groups:  sham,  2K1C  control,  captopril  (30  mg/kg),  ﬂax
lignan  concentrate  (200, 400  and 800  mg/kg).  Flax  lignan  concentrate  and  captopril  were  administered
daily  for eight  consecutive  weeks.  Sham-operated,  and  2K1C  control  rats  received  the  vehicle.  Treat-
ment  with  ﬂax  lignan  concentrate  (400  and  800  mg/kg)  signiﬁcantly  and  dose-dependently  restored  the
hemodynamic  parameters  systolic  blood  pressure,  diastolic  blood  pressure,  mean  arterial  blood  pressure
and left  ventricular  functions.  The  ﬂax  lignan  concentrate  signiﬁcantly  restored  the  elevated  hepatic,
renal  and  cardiac  marker  enzymes  in  the  serum.  It also  restored  the organs  weights  (kidney  and  heart),
serum  electrolyte  level  and  histological  abnormalities.  Furthermore,  ﬂax  lignan  concentrate  signiﬁcantly
elevated  the  level  of biochemical  markers  that  is  enzymatic  antioxidants  superoxide  dismutase,  glu-
tathione  and  decreased  malondialdehyde  in  the  heart  and  kidney  tissues.  Meanwhile,  we  found  that
plasma  nitric  oxide  and  plasma  nitric oxide  synthase  contents  were  signiﬁcantly  increased  in  the  ﬂax
lignan  concentrate-treated  group,  and  plasma  endothelin-1  and  renal  angiotensin-II  levels  were  signif-
icantly lower  than  2K1C  hypertensive  group.  In conclusion,  the  antihypertensive  and  antioxidant  effect
of  ﬂax  lignan  concentrate  were  dose-dependent  and  at the  highest  dose (i.e.  800  mg/kg)  similar  to those
of  captopril  (30  mg/kg).  It  is suggested  that  ﬂax lignan  concentrate  reduced  blood  pressure  by  reduction
of  renal  angiotensin-II  level,  inhibition  of plasma  endothelin-1  production,  induction  of the  nitric  oxide,
nitric  oxide  synthase  and in  vivo  antioxidant  defense  system.
© 2016  Sociedade  Brasileira  de Farmacognosia.  Published  by Elsevier  Editora  Ltda.  This  is  an open
he  CCaccess  article  under  t
ntroduction
The one-third adult population of the world is affected by hyper-
ension, and it can be considered as one of the most common
hronic disease nowadays (Lee et al., 2009; Gosavi et al., 2011;
hosh et al., 2012; Shivakumar et al., 2014). The world’s adult pop-
lation with hypertension is likely to increase from one billion in
000 to 1.56 billion by 2025 (Kearney et al., 2005).
Renin–angiotensin–aldosterone system (RAAS) plays an impor-
ant role in hypertension. Renal ischemia leads to secrete renin by
idney tissue which is responsible for catalyzing the hydrolysis
f angiotensin-I (Ang-I) from the N-terminus of angiotensino-
en. Ang-I is converted into Ang-II by the angiotensin-converting
nzyme (ACE). Ang-II is the primary product of RAAS, which
∗ Corresponding author.
E-mail: subhash.bodhankar@bharatividyapeeth.edu (S.L. Bodhankar).
http://dx.doi.org/10.1016/j.bjp.2016.05.005
102-695X/© 2016 Sociedade Brasileira de Farmacognosia. Published by Elsevier Edit
reativecommons.org/licenses/by-nc-nd/4.0/). BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/).
leads to vasoconstriction and hypertension through binding to the
Ang-II receptor and stimulating synthesis of aldosterone (Kamble
et al., 2013; Badole et al., 2015). It is well known that Ang-II
also stimulate the generation of superoxide anion radical (O2−•)
(Griendling et al., 1994; Rajagopalan et al., 1996), which con-
tribute to decreased nitric oxide (NO) bioavailability and impaired
endothelium-dependent vasorelaxation (Gryglewski et al., 1986).
Synthetic ACE inhibitors therapy is commonly used today to treat
hypertension. However, this advanced antihypertensive therapy
has serious side effects such as angioedema and dry cough (Coulter
and Edwards, 1987). Therefore, the use of anantioxidant may  be
the possible therapy for the prevention and treatment of hyper-
tension with the established antihypertensive drug (Gosavi et al.,
2011, 2014; Visnagri et al., 2013).Flaxseed or linseed (Linum usitatissimum L., Linaceae) is brown
or yellow colored seed harvested from the blue ﬂowers of ﬂax
crop. It has been used as food in India and around the world
for a long time. Flaxseed mainly contains omega-3 fatty acid,
ora Ltda. This is an open access article under the CC BY-NC-ND license (http://
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-linolenic acid, dietary ﬁber and secoisolariciresinol diglucoside
SDG) lignan (Bassett et al., 2009). Flaxseed contains ten to hun-
red times more lignan than most other edible plants seeds. It is
eported that ﬂaxseed also contains other lignans like matairesinol,
ariciresinol, hinokinin, arctigenin, pinoresinol and demethoxy
ecoisolariciresinol in small quantity with several phenolic acid
ompounds (Prasad et al., 1998; Johnsson et al., 2000). Antidiabetic
Prasad et al., 2000), antihyperlipidemic (Raygude et al., 2012a),
ardioprotective (Zanwar et al., 2011, 2013), renoprotective (Ghule
t al., 2011, 2012, 2015), antiatherogenic (Prasad, 1997; Prasad
t al., 1998), antioxidant, anticancer, antiviral, bactericidal and anti-
nﬂammatory (Chen et al., 2002; Collins et al., 2003; Kinniry et al.,
006; Rajesha et al., 2006; Zanwar et al., 2010) potentials of ﬂaxseed
ave been already reported.
Clinical studies involving patients with peripheral artery dis-
ase and high blood pressure (Rodriguez-Leyva et al., 2013; Khalesi
t al., 2015) reported that consumption of ﬂaxseeds in the diet for
he duration of more than three months lowered blood pressure.
he antihypertensive potential of ﬂax lignan in chronic hyperten-
ive condition has not been well explained in animals. The objective
f the present work was to study the effect of ﬂax lignan concen-
rate (FLC) in two- kidney, one-clip (2K1C) induced hypertension
n Wistar rats.
aterials and methods
xperimental protocol
Male Wistar rats weighing (200–250 g) were purchased from
ational Toxicology Centre, Pune, India. They were maintained
t 25 ± 1 ◦C temperature and 45–55% relative humidity under
2 h light/dark cycle. The animals had access to food pellets
manufactured by Pranav Agro Industries Ltd., Sangli, India) and
ater ad libitum.  The experimental protocol was approved by the
nstitutional Animal Ethics Committee (IAEC) constituted as per
uidelines of Committee for the Purpose of Control and Supervi-
ion of Experiments on Animal (CPCSEA), India. The IAEC approval
umber is CPCSEA/PCL/08/2014-15.
rugs and chemicals
Captopril, sulfanilic acid, N-(1-naphthyl) ethylenediamine was
urchased from Sigma–Aldrich Corporation, USA. Absolute alco-
ol (manufactured by Changshu Yangyuan Chemicals, China) was
urchased from the respective vendor. Analytical grade hexane,
ydrochloric acid, and sodium hydroxide were purchased from
ualigenes Fine Chemicals Pvt. Ltd., Mumbai, India.
ollection and authentication of plant seeds
Seeds of Linum usitatissimum L., Linaceae (ﬂaxseeds) were
btained from Punjabrao Deshmukh Krishi Vidyapeeth, College of
griculture, Nagpur, India. After the authentication of the seeds,
 voucher specimen was deposited at our Institute, Poona College
f Pharmacy, Pune, India. The ﬂaxseeds were stored in a cold room
efore processing for oil extraction at our Real World Nutrition Lab,
harati Vidyapeeth Deemed University, Pune, India.
reparation of ﬂax lignan concentrate (FLC)
Preparation of FLC was  carried out as described previously
Zanwar et al., 2013). The ﬂaxseed cake was defatted by hexane
o remove residual oil. The defatted cake was then hydrolyzed
ith aqueous sodium hydroxide for 1 h at room temperature with
ntermittent shaking followed by extraction with 50% ethanol. The de Farmacognosia 26 (2016) 601–610
ﬁltrate was acidiﬁed to pH 3 using 1 M hydrochloric acid. The ﬁl-
trate was  dried using rotavac apparatus at 50 ◦C. The dry powder of
hydroalcoholic extract was  labeled as FLC.
Preparation of drug solution and selection of FLC dose
Captopril and FLC were dissolved in distilled water. This study
was carried out using three doses of FLC (i.e. 200, 400 and
800 mg/kg, p.o.) and one dose of captopril (i.e. 30 mg/kg, p.o.).
Experimental induction of hypertension
Wistar rats weighing 200–250 g were anesthetized with
50 mg/kg intraperitoneal administration of thiopental sodium. The
fur on the back of each rat was  shaved, and the skin was disin-
fected. A ﬂank incision was made in the left lumbar area parallel
to the long axis of the rat. The renal pedicel was exposed with
the kidney retracted to the abdomen. Left renal artery was con-
stricted to induce two-kidney, one-clip hypertension (2K1C), as
previously described by Kharin and Krandycheva (2004). Brieﬂy,
a loop of the left renal artery was pulled into a segment of
polyurethane tube [MRE 040-S20, Braintree Scientiﬁc; internal
diameter (ID) = 0.50 mm,  length 2 mm].  The muscle and skin layer
(incision site) were sutured with a highly sterile suture needle. After
one week of the recovery period, the animals were used for the
further experiment. Rats in sham-operated group underwent the
exposure of the left renal artery, but the artery was not constricted.
The muscle and skin layer (incision site) were sutured with a sterile
suture needle. After one week of the recovery period, the animals
were used for the further experiment.
Experimental design
The rats were randomly divided into six groups, each containing
six rats:
Group I: Sham-operated (vehicle distilled water p.o.)
Group II: 2K1C control (vehicle distilled water p.o.)
Group III: 2K1C + captopril (30 mg/kg p.o.)
Group IV: 2K1C + FLC (200 mg/kg p.o.)
Group V: 2K1C + FLC (400 mg/kg p.o.)
Group VI: 2K1C + FLC (800 mg/kg p.o.)
FLC and captopril were and administered to the rats orally using
an oral feeding needle daily for eight consecutive weeks. The sham-
operated and 2K1C control rats received vehicle distilled water. At
the end of the study period, blood was collected by a retro-orbital
puncture for the measurement of biochemical parameters.
Assessment of hemodynamic changes
Each rat was  anesthetized with intraperitoneal injection of
urethane (1.25 g/kg). The trachea was  cannulated to assist respi-
ration. The systolic blood pressure (SBP), diastolic blood pressure
(DBP) and mean arterial blood pressure (MABP) were measured
by invasive technique at the end of the eighth week. A polyethyl-
ene cannula (PE 50) ﬁlled with heparinized saline (100 IU/ml) was
inserted into the right carotid artery. The cannula was  connected
to a transducer and the signal was  ampliﬁed. The left ventricu-
lar hemodynamic changes were measuredusing a Millar mikro-tip
transducer catheter (Model SRP-320; Millar Instrument, Inc. 320-
7051, Houston, TX 77023-5417) inserted into the left ventricle
via the right carotid artery and connected to a bioampliﬁer (Adil
et al., 2015, 2016a; Visnagri et al., 2015). Maximum ﬁrst deriva-
tive of ventricular pressure (dP/dtmax), minimum ﬁrst derivative of
ventricular pressure (dP/dtmin) and left ventricular end-diastolic
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ressure (EDP) signals were obtained from primary signals (left
entricular systolic pressure and blood pressure) by means of Pow-
rlab 8-channel data acquisition system (AD Instruments Pvt. Ltd.,
ith Lab Chart 7.3 Prosoftware, Australia).
ample collection and determination of biomarkers
erum and plasma sample collection
At the end of the study period and 1 h after the test substance
dministration, the blood was collected by retro-orbital puncture
nder anesthesia. Serum samples were collected without added
nticoagulant. Serum samples were collected after centrifugation
or 10 min  at 845 × g and 4 ◦C. The blood was collected into anti-
oagulant containing tubes and immediately centrifuged (10 min
t 845 × g and 4 ◦C temperatures) for plasma sample collection.
he serum and plasma samples were stored at −80 ◦C until being
nalyzed.
eart and renal tissue samples
At the end of the experimental period, all the rats were
umanely euthanized. The heart and kidneys were removed
or further experiments. The portions of the heart and clipped
enal tissues were individually homogenized in 10% cold
ris–hydrochloride buffer (10 mmol/l, pH 7.4) using tissue homog-
nizer (Remi, India) and centrifuged at 5283 × g for 15 min  at 0 ◦C.
he clear supernatant collected after the centrifugation was used
or biochemical and molecular estimations.
easurement of biological serum markers
The serum electrolytes such as Na+, K+ and Cl− were estimated
sing commercially available measurement kits (Coral Clinical Sys-
em, Goa, India). Creatine kinase (CK-MB), lactate dehydrogenase
LDH), aspartate aminotransferase (AST), alanine aminotransferase
ALT), alkaline phosphatase (ALP), total protein, blood urea nitrogen
BUN), uric acid and creatinine were also measured by using com-
ercially available measurement kits (Accurex Pvt. Ltd., Mumbai,
ndia).
stimation of endogenous antioxidant enzyme
The superoxide dismutase (SOD) concentration was  determined
y the method previously described elsewhere (Kamble et al., 2013;
dil et al., 2014; Aswar et al., 2015; Honmore et al., 2015). The
OD activity was expressed as U/mg of protein. The glutathione
GSH) assay was performed according to the method previously
escribe elsewhere (Moron et al., 1979; Kandhare et al., 2011a,
015a; Kumar et al., 2014; Ketkar et al., 2015; Goswami et al.,
016; Adil et al., 2016b). The amount of reduced glutathione was
xpressed as g/mg of protein. Malondialdehyde (MDA) level in the
idney and heart tissues were measured by the method previously
escribed elsewhere (Slater and Sawyer, 1971; Patil et al., 2011,
015; Raygude et al., 2012a,b; Saraswathi et al., 2014; Kandhare
t al., 2016a), and the values were expressed in nanomoles of
DA/mg of protein.
etermination of nitric oxide (NO), nitric oxide synthase (NOS),
ndothelin-1 (ET-1), Ang-II level
NO is highly unstable free radical, which is converted into sta-
le metabolites nitrate and nitrite in the equimolar ratio (Schlaich
t al., 2007; Visnagri et al., 2014; Kandhare et al., 2016a, 2015b;
arkar et al., 2015). The plasma NO level was determined as nitrite
y the acidic Griess reaction. The assay was performed by a rapid,
imple spectrophotometric method described elsewhere (Miranda
t al., 2001; Gosavi et al., 2012a,b; Kandhare et al., 2013a, 2014a).
he principle of this assay is a reduction of nitrate by vanadium.
he nitrite reacts with sulfonamide and N-(1-naphthyl) ethylenedi-
mine to produce a pink azo-product with maximum absorbance at de Farmacognosia 26 (2016) 601–610 603
543 nm.  The concentrations were calculated using a standard curve
of sodium nitrate and the results were expressed in mol/l. ET-1,
NOS [Genxbio Health Sciences Ltd., India] in the plasm and Ang-II
level [RayBiotech, Inc., USA] in the renal tissue homogenate were
measured using Elisa kits as per the instructions are given by the
manufacturer.
Histopathological examination
The excised heart and kidney samples were cleaned and
immediately ﬁxed in neutral buffered 10% formalin solution. The
specimens were routinely processed and embedded in parafﬁn. The
specimens were cut in sections of 5 m thickness by microtome
and stained with Masson’s trichrome for microscopic examination.
The sections were observed under the microscope and photomicro-
graphs of the tissue section were taken using a microscope camera
(Nikon Cool pix). The parameters of histopathological assessment
of the kidney sections were mainly perivascular edema, ﬁbrosis,
glomerular necrosis and collagen deposition. The parameters of
histopathological assessment of the heart sections were myocardial
degeneration, collagen deposition, and ﬁbrosis.
Statistical analysis
The data were expressed as mean ± standard error of mean
(SEM) and statistical analysis was  carried out by one-way ANOVA
followed by post hoc Dunnett’s test using Graph Pad Prism 5.0 soft-
ware (Graph Pad Software, San Diego, CA, USA). Differences with a
value of p < 0.05 were considered statistically signiﬁcant.
Results
Effect of FLC on hemodynamic parameters and left ventricular
contractile function of heart
Fig. 1 presents the effect of three different concentrations (200,
400 and 800 mg/kg) on hemodynamic parameters and left ven-
tricular contractile function in all the I–VI groups after 8 weeks.
Compared to sham operated group, the rats in 2K1C control group
showed signiﬁcant (p < 0.001 each) increase in SBP, DBP, MABP,
EDP, dP/dtmax and dP/dtmin after 8 weeks. Captopril (30 mg/kg)
and FLC (800 mg/kg) treatment showed a signiﬁcant (p < 0.001
each) decrease in the SBP, DBP, MABP, EDP, dP/dtmax and dP/dtmin.
FLC (400 mg/kg) treatment also showed signiﬁcant (p < 0.01 each)
decrease in SBP, DBP, MABP, EDP, dP/dtmax and dP/dtmin compared
to 2K1C-control group. Treatment with FLC (200 mg/kg) showed
signiﬁcant (p < 0.05) decrease in SBP, and dP/dtmin; but did not show
any signiﬁcant decrease in DBP, MABP, EDP  and dP/dtmax values
(Fig. 1).
Effect of FLC on organs weight and electrolyte
The 2K1C-control hypertensive (group-II) rats showed signiﬁ-
cant (p < 0.001) increase in the weights of kidney and heart. The
serum sodium ion (Na+) and chloride ion (Cl−) levels signiﬁcantly
increased while that of serum potassium ion (K+) level decreased
compared to sham. The treatments with captopril (30 mg/kg)
and FLC (400, 800 mg/kg) reduced organs weight and restored
those ions (sodium, chloride, and potassium) level to near normal
(Table 1).
Effect of FLC on serum cardiac, hepatic and renal markers and
serum total protein level
The activities of CK-MB, LDH, AST, ALT, ALP, total protein,
BUN, uric acid and creatinine were signiﬁcantly increased in 2K1C
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Fig. 1. Effect of administration of FLC and captopril on hemodynamic parameters (A) SBP, (B) DBP, (C) MABP, (D) EDP, (E) dP/dtmax and (F) dP/dtmin in modiﬁed 2K1C
hypertensive Wistar rats (n = 6). Data are expressed as mean ± S.E.M. and statistical analysis was carried out by one-way ANOVA followed by post hoc Dunnett’s test;
ns  = non-signiﬁcant, *p < 0.05, **p  < 0.01, ***p < 0.001 as compared with 2K1C control group-II, #p < 0.05, ##p < 0.01, ###p < 0.001 compared to sham group-I.
Table 1
Effect of FLC (200, 400 and 800 mg/kg) and captopril (30 mg/kg) on organs (heart and kidney) weights and serum electrolytes in 2K1C hypertensive Wistar rats.
Parameter Treatment
Sham 2K1C control 2K1C + captopril
(30 mg/kg)
2K1C + FLC
(200 mg/kg)
2K1C + FLC
(400 mg/kg)
2K1C + FLC
(800 mg/kg)
Organ weight (g)
Heart weight 1.18 ± 0.03 1.54 ± 0.04d 1.20 ± 0.02c 1.44 ± 0.04ns 1.38 ± 0.05b 1.27 ± 0.02c
Kidney weight 1.41 ± 0.03 2.18 ± 0.05d 1.53 ± 0.04c 2.02 ± 0.05ns 1.94 ± 0.05b 1.62 ± 0.04c
Electrolyte (mEq/l)
Sodium 144 ± 1.57 183 ± 6.29d 152 ± 3.39c 179 ± 5.45ns 161 ± 5.03b 155 ± 3.75c
Potassium 6.22 ± 0.22 3.67 ± 0.19d 5.73 ± 0.27c 3.81 ± 0.19ns 4.65 ± 0.20b 5.4 ± 0.15c
Chloride 104 ± 2.12 131 ± 4.21d 115 ± 1.66c 126 ± 2.5ns 120 ± 2.1a 116 ± 1.79b
Values are expressed as mean ± SEM for n = 6 rats. Data are expressed as mean ± S.E.M. and statistical analysis was carried out by one-way ANOVA followed by post hoc
Dunnett’s test; ns = non-signiﬁcant.
a p < 0.05 as compared with 2K1C control (group-II).
b p < 0.01 as compared with 2K1C control (group-II).
c p < 0.001 as compared with 2K1C control (group-II).
d p < 0.001 compared to sham group (I).
Table 2
Effect of FLC (200, 400 and 800 mg/kg) and captopril (30 mg/kg) on serum cardiac, hepatic, renal markers and serum total protein in 2K1C hypertensive Wistar rats.
Parameter Treatment
Sham 2K1C control 2K1C + captopril
(30 mg/kg)
2K1C + FLC
(200 mg/kg)
2K1C + FLC
(400 mg/kg)
2K1C + FLC
(800 mg/kg)
Aspartate aminotransferase (AST) (IU/l) 90.6 ± 3.21 162 ± 5.69d 108 ± 5.53c 144 ± 4.09ns 136 ± 4.96b 121 ± 3.97c
Alanine aminotransferase (ALT) (IU/l) 37.5 ± 2.13 75.3 ± 1.82d 50.8 ± 2.75c 68.6 ± 2.37ns 62.5 ± 1.38b 59.9 ± 3.05c
Alkaline phosphatase (ALP) (IU/l) 73.1 ± 4.54 186 ± 6.98d 129 ± 13.6c 166 ± 8.22ns 140 ± 9.48b 140 ± 10b
Total protein (mg/dl) 5.31 ± 0.22 8.50 ± 0.33d 6.01 ± 0.27c 7.54 ± 0.24ns 7.00 ± 0.26b 5.98 ± 0.29c
Blood urea nitrogen (BUN) (mg/dl) 17.80 ± 0.70 36.10 ± 1.81d 23.80 ± 1.38c 31.10 ± 1.05a 29.40 ± 1.27b 27.20 ± 1.05c
Uric acid (mg/dl) 1.93 ± 0.08 3.90 ± 0.15d 2.22 ± 0.07c 3.52 ± 0.10a 3.38 ± 0.10b 2.98 ± 0.09c
Creatinine (mg/dl) 0.77 ± 0.07 1.83 ± 0.04d 0.90 ± 0.05c 1.49 ± 0.12ns 1.36 ± 0.14b 1.12 ± 0.09c
Creatinine kinase (CK-MB) (IU/l) 345 ± 13.9 563 ± 16.6d 464 ± 14.1c 531 ± 11.4ns 500 ± 10.6b 484 ± 11.5c
Lactatedehydrogenase (LDH) (IU/l) 655 ± 10.6 770 ± 10.7d 672 ± 8.1c 732 ± 12.6a 712 ± 9.72b 680 ± 5.71c
Values are expressed as mean ± SEM for n = 6 rats. Data are expressed as mean ± S.E.M. and statistical analysis was carried out by one-way ANOVA followed by post hoc
Dunnett’s test; ns = non-signiﬁcant.
a p < 0.05 as compared with 2K1C control (group-II).
b p < 0.01 as compared with 2K1C control (group-II).
c p < 0.001 as compared with 2K1C control (group-II).
d p < 0.001 compared to sham group (I).
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Table  3
Effect of FLC (200, 400 and 800 mg/kg) and captopril (30 mg/kg) on endogenous antioxidant enzymes in 2K1C hypertensive Wistar rats.
Parameter Treatment
Sham 2K1C control 2K1C + captopril
(30 mg/kg)
2K1C + FLC
(200 mg/kg)
2K1C + FLC
(400 mg/kg)
2K1C + FLC
(800 mg/kg)
SOD (Unit/mg protein)
Kidney 12.47 ± 0.27 5.58 ± 0.21d 9.16 ± 0.34c 6.61 ± 0.34ns 7.21 ± 0.44b 8.62 ± 0.32c
Heart 4.6d7 ± 0.39 3.04 ± 0.08d 4.25 ± 0.11c 3.32 ± 0.17ns 4.13 ± 0.11b 4.22 ± 0.08c
MDA  (nmol of MDA/mg protein)
Kidney 3.42 ± 0.23 7.93 ± 0.31d 4.33 ± 0.28c 6.95 ± 0.17a 6.44 ± 0.20b 5.45 ± 0.29c
Heart 4.35 ± 0.24 8.06 ± 0.23d 5.86 ± 0.09c 7.80 ± 0.16ns 6.91 ± 0.13b 6.05 ± 0.25c
GSH (g/mg protein)
Kidney 8.11 ± 0.26 4.58 ± 0.26d 6.41 ± 0.21c 4.94 ± 0.28ns 5.66 ± 0.18b 5.99 ± 0.15c
Heart 7.76 ± 0.36 3.91 ± 0.24d 6.74 ± 0.20c 3.86 ± 0.23ns 5.14 ± 0.15b 5.34 ± 0.18c
Values are expressed as mean ± SEM for n = 6 rats. Data are expressed as mean ± S.E.M. and statistical analysis was  carried out by one-way ANOVA followed by post hoc
Dunnett’s test; ns = non-signiﬁcant.
a p < 0.05 as compared with 2K1C control (group-II).
b p < 0.01 as compared with 2K1C control (group-II).
c p < 0.001 as compared with 2K1C control (group-II).
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ypertensive rats (2K1C-control group-II). The treatment with cap-
opril (30 mg/kg) and FLC (200, 400, 800 mg/kg) showed a reduction
n the activities of these cardiac, hepatic and renal markers toward
ear normal. Captopril (30 mg/kg) showed the highest activity
han the test drug FLC (200, 400, 800 mg/kg). FLC (800 mg/kg)
howed signiﬁcant (p < 0.001) reduction in serum level of all mark-
rs, except in ALP (p < 0.01). Treatment with FLC (400 mg/kg) also
howed signiﬁcant (p < 0.01) reduction in serum level of all markers.
owever, FLC in low dose (200 mg/kg) did not show any signiﬁcant
nhibition in the level of serum CK-MB, LDH, AST, ALT, ALP, total pro-
ein, and creatinine; but showed a signiﬁcant reduction in serum
evel of BUN and uric acid compared to the 2K1C control animals
Table 2).
ndogenous antioxidant enzymes
The SOD and GSH activity in the tissues (kidney and heart)
f 2K1C hypertensive rats were decreased signiﬁcantly (p < 0.001)
fter 8 weeks. Captopril (30 mg/kg), as well as FLC (400, 800 mg/kg),
estored the SOD and GSH activity in the tissues (kidney and heart)
fter eight weeks. On the other hand, FLC (200 mg/kg) did not
how any signiﬁcant restoration of the SOD and GSH activity in
he tissues. MDA  level in the tissues (kidney and heart) of 2K1C
ypertensive rats increased signiﬁcantly after 8 weeks. Captopril
30 mg/kg) and FLC (800 mg/kg) treated groups had signiﬁcantly
ecrease the level of MDA  than in the FLC (400 mg/kg) treated
roup. However, FLC (200 mg/kg) treated group did not show any
igniﬁcant restoration of MDA  level (Table 3).
ffect of FLC on NO, NOS, Ang-II and ET-1 level
The 2K1C-control rats showed a signiﬁcant decrease in plasma
O and NOS level as compared to the sham operated group rats. The
ats treated with captopril (30 mg/kg) and FLC (400 and 800 mg/kg)
igniﬁcantly elevated plasma NO and plasma NOS levels. However,
K1C hypertensive rats treated with FLC (200 mg/kg) did not show
ny signiﬁcant effect (Fig. 2A and B).
The increased blood pressure in the 2K1C hypertensive rats
as also linked with signiﬁcantly increased kidney Ang-II levels
ompared with sham-operated group. Captopril (30 mg/kg) and
LC (400 and 800 mg/kg) treatment in 2K1C hypertensive rats
howed decreases in Ang-II levels of the kidney (Fig. 2C). Plasma
T-1 level was elevated signiﬁcantly in the 2K1C-control groupcompared with sham group. Captopril (30 mg/kg) and FLC (400
and 800 mg/kg) signiﬁcantly decreased the plasma ET-1 level
dose-dependently toward near normal level (Fig. 2D).
Effect of FLC on histopathology of kidney
The histopathological examination of kidney tissues in the
sham-operated rats showed normal glomerulus cell and tubuli with
the absence of perivascular edema, ﬁbrosis, and collagen deposi-
tion. On the other hand, the hypertensive 2K1C group rats showed
a signiﬁcant increase in perivascular edema, ﬁbrosis, and colla-
gen deposition. Captopril (30 mg/kg) and FLC (400 and 800 mg/kg)
showed a decrease in perivascular edema, ﬁbrosis, collagen depo-
sition, and necrosis. However, FLC (200 mg/kg) did not show
signiﬁcant protection from hypertensive damage (Fig. 3).
Effect of FLC on histopathology of heart
The 2K1C hypertensive group rats showed severe myocar-
dial degeneration, hypertrophy, and ﬁbrosis. Captopril (30 mg/kg)
treated group showed minimal myocardial degeneration and col-
lagen deposition and ﬁbrosis. FLC (400 and 800 mg/kg) treatment
also showed a decrease in myocardial degeneration and collagen
deposition and ﬁbrosis. However, FLC (200 mg/kg) did not show
any signiﬁcant protection (Fig. 4).
Discussion
The 2K1C is a classical method to induce hypertension in rats
similar to human, which is primarily based on RAAS (Thurston et al.,
1980; Ponchon and Elghozi, 1996; Kandhare et al., 2011b). The main
mechanism behind the 2K1C hypertension is RAAS rather than a
disturbance in kidney function (Nogueira et al., 2012). Unilateral
renal artery occlusion decreases perfusion pressure inside the kid-
ney and stimulates renin synthesis, which then produce Ang-II and
increases the peripheral resistance and blood pressure (Pickering,
1989).
Our study demonstrated that higher doses of FLC (400 and
800 mg/kg) signiﬁcantly decreased systolic, diastolic and mean
arterial blood pressures in the 2K1C hypertensive Wistar rats.
Secoisolariciresinol diglucoside (SDG), a main constituent of FLC,
is reported to have a similar type of results in normotensive and
Ang-I induced acute hypertensive animals. It is postulated that
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Fig. 2. Effect of administration of FLC and captopril on plasma NO levels (A), plasma NOS activity (B), Ang-II of clipped kidney (C) and plasma ET-1 (D) in 2K1C hypertensive
Wistar rats (n = 6). Data are expressed as mean ± S.E.M. and statistical analysis was  carried out by one-way ANOVA followed by post hoc Dunnett’s test; ns = non-signiﬁcant,
*p  < 0.05, **p  < 0.01, ***p < 0.001 as compared with 2K1C control group-II, #p < 0.05, ##p < 0.01, ###p < 0.001 compared to sham group-I.
Fig. 3. Effect of administration of FLC and captopril on kidney histology in 2K1C hypertensive Wistar rats. Photomicrograph of sections of lungs of (A) Sham-operated rats
(group-I) showed normal glomerulus cell and tubular with the absence of perivascular edema and collagen deposition. (B) 2K1C control rats (group-II) showed a signiﬁcant
increase  in collagen deposition and perivascular edema, necrosis. (C) 2K1C + captopril (30 mg/kg) (group-III) showed a decrease in collagen deposition, atrophy, and necrosis.
(D)  2K1C + FLC (200 mg/kg) (group-IV) showed no signiﬁcant protection against hypertension (E) 2K1C + FLC (400 mg/kg) (Group V) showed decrease in collagen deposition
and  perivascular edema, glomerulus necrosis (F) 2K1C + FLC (800 mg/kg) (Group VI) showed signiﬁcantly reduced perivascular edema, ﬁbrosis, glomerular necrosis and
collagen  deposition (Masson’s trichrome 20×).
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Fig. 4. Effect of administration of FLC and captopril on heart histology in 2K1C hypertensive Wistar rats. Photomicrograph of sections of lungs of (A) sham-operated rats (group-
I)  showed normal cardiac muscle ﬁbers with the absence of myocardial ﬁbrosis. (B) 2K1C control (group-II) showed severe myocardial degeneration, hypertrophy, and ﬁbrosis.
(C)  2K1C+ Captopril (30 mg/kg) (group-III) showed minimal myocardial degeneration and collagen deposition and myocardial ﬁbrosis. (D) 2K1C + FLC (200 mg/kg) (group-IV)
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thowed no signiﬁcant decrease in collagen deposition and myocardial ﬁbrosis. (E)
ollagen deposition and ﬁbrosis. (F) 2K1C + FLC (800 mg/kg) (Group VI) showed a sign
richrome 20×).
he activity of SDG may  be due to the stimulation of guanylate
yclase-nitric oxide pathway and by inhibition of angiotensin
onverting enzyme (ACE) (Prasad, 2004; Kamble et al., 2013).
arlier, we have determined SDG content in FLC by using high-
erformance liquid chromatography (HPLC) analysis and reported
lood pressure lowering effect of FLC in DOCA-salt-induced renal
ypertension model in rats (Sawant and Bodhankar, 2016). In the
resent study, the effect of FLC on the renin–angiotensin system
ependent 2K1C hypertensive rat, similar to those of captopril,
ead us to consider that SDG a main constituent from FLC may
ossess ACE-inhibitor-like properties. However, the possibility
f a potentiating effect of SDG by other ﬂavonoids and minor
onstituents present in FLC cannot be ruled out.
The hemodynamic data showed that left ventricle end diastolic
ressure, max  dP/dt and min  dP/dt increased in 2K1C hypertensive
ats, which are a clear sign of increased preload and afterload in the
eart. The altered left ventricular parameters in 2K1C hypertensive
ats also showed decrease contractility, diastolic compliance and
ysfunction in the heart (Wang et al., 2007; Junhong et al., 2008).
LC and captopril are restored EDP, max  dP/dt and min  dP/dt sig-
iﬁcantly indicated that FLC and captopril decreased the burden on
he heart, increased the conformity of myocardium and improved
ardiac function. These ﬁndings thus support that FLC containing
DG as main constituent has antihypertensive potential in 2K1C
ypertensive rats.
Chronic hypertension leads to continuous accumulation of
nterstitial collagen ﬁbers and an increase in heart weight (Rossi
nd Peres, 1992). It is proved that Ang-II of RAAS is also involved
n the tissue hypertrophy or hyperplasia. Therefore, RAAS plays
n important role in the weight increase of heart and kidney in
he 2K1C hypertensive model (Kobayashi et al., 1999). The current + FLC (400 mg/kg) (Group V) showed a decrease in myocardial degeneration and
t reduction in myocardial degeneration, collagen deposition, and ﬁbrosis (Masson’s
results showed the captopril and FLC signiﬁcantly prevent the
increase in kidney and heart weight associated with hypertrophy,
which may  be due to antihypertensive effects of captopril and FLC.
It is well known that intracellular sodium ion concentration
increases and potassium ion concentration decreases signiﬁcantly
in hypertension (Adrogue and Madias, 2007). Our results are
thus, in accordance with the previous study and suggested that
restoration of serum sodium and potassium ion may  be due to
antihypertensive effects of FLC.
The liver plays an important role in metabolism, toxicity and
elimination of endogenous and exogenous elements. Liver damage
leads to increased activity of AST, ALT, ALP and total protein in the
plasma (Navarro et al., 1993; Bhattacharjee et al., 2009; Visnagri
et al., 2012; Kandhare et al., 2013b,c, 2015d; Sarkate et al., 2015;
Devkar et al., 2016). The reason behind the elevation of AST, ALT,
ALP and total protein in the 2K1C hypertension may be oxidative
stress that caused leakage of these enzymes from liver tissues due to
membrane damage. After the administration of FLC and captopril,
there was a signiﬁcant decrease in the serum activities of AST, ALT,
ALP and total protein that clearly signiﬁes that captopril and FLC
protected the functional capacity of liver and prevented oxidative
damage due to hypertension.
In hypertension, volume and pressure loads on the kidneys lead
to the dysfunction and damage to the renal tissues (Möhring et al.,
1975; Kandhare et al., 2015d). Blood urea nitrogen (BUN), serum
creatinine, and uric acid are considered as markers of the renal func-
tion. They are produced due to disturbance of protein and nucleic
acid metabolism in the hypertensive stress. Several animal stud-
ies of 2K1C hypertension have reported that hypertension elevates
the levels of blood urea nitrogen, serum creatinine and uric acid
(Kang et al., 2002; Amat et al., 2014). The oxidative stress caused
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ue to high blood pressure may  be the reason for the elevated
evels of BUN, creatinine, and uric acid in the serum (Kandhare
t al., 2012a,b,c,d, 2015c). The current study showed a reduction
n the elevated serum level of renal markers by FLC and explain its
rotective effect in 2K1C hypertensive rats. Hypertension induces
yocardial damage, and the serum levels of CK-MB and LDH are
onsidered as standard markers for the identiﬁcation of cardiac
amage (Mair et al., 1994). The decreased serum level of these
nzymes in the FLC-treated groups offered protection to heart in
he 2K1C hypertension.
The present study showed that the activity of SOD and GSH in
he heart and kidney tissues of 2K1C control group was  lower than
hat in the sham-operated group. On the other hand, MDA  activity
n the 2K1C control group was signiﬁcantly higher than in the sham-
perated group. Our results thus suggested that hypertension led to
ncreased oxidative stress, which is in agreement with the previous
tudy (Cao et al., 2013). The current study showed that FLC and
aptopril administration scavenging the oxygen free radical in the
lood leading to their anti-oxidant effects.
Blood ﬂow-induced shear stress on endothelial cells plays key
ole in the production of NO by the endothelial NOS (Pohl et al.,
986; Kandhare et al., 2012d, 2014b, 2016b). NO is vasorelaxant
ubstance and physiological antagonist of the Ang-II of RAAS at
ascular levels. Ang-II reduces NO bioavailability by promoting
uperoxide anion, which is responsible for vasoconstriction and
ncrease in blood pressure (De Nicola et al., 1992; Cosentino et al.,
994; Zhou et al., 2014).
The antagonistic effects of NO and Ang-II come out also in inter-
ctions with other vasoactive substance ET-1, which is the potent
asoconstrictor released from the endothelium (Rubanyi, 1994;
hou et al., 2014). ET-1 is overexpressed in the vasculature and
lood in various models of hypertension, including the 2K1C model,
hich increases systemic blood pressure (Iglarz and Schiffrin, 2003;
ao et al., 2013). In the present study, these biomarkers were
ltered in the 2K1C control hypertensive rats, where simulta-
eously the blood pressure increased with Ang-II and ET-1, as a
ynthesis of NO and NOS decreased. All these changes were opposed
igniﬁcantly by the ACE inhibitor drug captopril and FLC. Dose-
ependent effects of FLC on the renin–angiotensin system markers
ere similar to those of captopril and suggest ACE inhibitor like
roperty of FLC.
Histological study of the rat heart and kidneys revealed that
he FLC treatment in the 2K1C hypertensive rats reduced cardiac
nd renal damage correlate with the various hemodynamic, bio-
hemical observations. These results support the antihypertensive
ctivity of FLC in the 2K1C hypertensive rats.
onclusion
Antihypertensive and antioxidant effects of FLC in 2K1C hyper-
ension were dose-dependent and at the highest dose (800 mg/kg)
imilar to those of captopril, which is mainly characterized by the
eduction in blood pressure, restoration of altered left ventricular
unctions and endogenous biomarkers. It is concluded that FLC may
educe blood pressure by reduction of kidney Ang-II level, inhibi-
ion of ET-1 production and induction of the NO, NOS and in vivo
ntioxidant defense system.thical statement
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